$3.07
Chromadex is a packaged foods business based in the US. Chromadex shares (CDXC) are listed on the NASDAQ and all prices are listed in US Dollars. Chromadex employs 106 staff and has a trailing 12-month revenue of around $83.2 million.
Our top picks for where to buy Chromadex stock
How to buy Chromadex stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CDXC. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Chromadex stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Chromadex stock price (NASDAQ: CDXC)
Use our graph to track the performance of CDXC stocks over time.Chromadex shares at a glance
Latest market close | $2.97 |
---|---|
52-week range | $1.25 - $4.65 |
50-day moving average | $2.90 |
200-day moving average | $2.27 |
Wall St. target price | $6.90 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.05 |
Is it a good time to buy Chromadex stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Chromadex price performance over time
Historical closes compared with the close of $2.97 from 2024-07-22
1 week (2024-07-17) | 2.06% |
---|---|
1 month (2024-06-24) | 16.47% |
3 months (2024-04-24) | -12.65% |
6 months (2024-01-24) | 103.42% |
1 year (2023-07-24) | 81.10% |
---|---|
2 years (2022-07-22) | 55.50% |
3 years (2021-07-23) | 9.42 |
5 years (2019-07-24) | 4.67 |
Chromadex financials
Revenue TTM | $83.2 million |
---|---|
Gross profit TTM | $42.8 million |
Return on assets TTM | -5.06% |
Return on equity TTM | -12.39% |
Profit margin | -4.24% |
Book value | $0.38 |
Market Capitalization | $209.6 million |
TTM: trailing 12 months
Chromadex share dividends
We're not expecting Chromadex to pay a dividend over the next 12 months.
Have Chromadex's shares ever split?
Chromadex's shares were split on a 1:3 basis on 12 April 2016. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Chromadex shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Chromadex shares which in turn could have impacted Chromadex's share price.
Chromadex share price volatility
Over the last 12 months, Chromadex's shares have ranged in value from as little as $1.25 up to $4.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chromadex's is 1.874. This would suggest that Chromadex's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Chromadex overview
ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN. com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States.
Frequently asked questions
nullWhat percentage of Chromadex is owned by insiders or institutions?
Currently 35.787% of Chromadex shares are held by insiders and 17.996% by institutions. How many people work for Chromadex?
Latest data suggests 106 work at Chromadex. When does the fiscal year end for Chromadex?
Chromadex's fiscal year ends in December. Where is Chromadex based?
Chromadex's address is: 10900 Wilshire Blvd, Los Angeles, CA, United States, 90024 What is Chromadex's ISIN number?
Chromadex's international securities identification number is: US1710774076 What is Chromadex's CUSIP number?
Chromadex's Committee on Uniform Securities Identification Procedures number is: 171077407
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question